Navigation Links
ACLA Opposes Proposed LabTax
Date:9/9/2009

Taxes Prevention, Raises Costs, Unfairly Targets Labs

WASHINGTON, Sept. 9 /PRNewswire-USNewswire/ -- "Senate Finance Committee Chairman Max Baucus' (D-MT) plan to impose $750 million in taxes on clinical laboratory testing services -- on top of other cuts -- translates into a disproportionate cut for laboratories, will damage efforts to enhance prevention and wellness, and raise health care costs," according to Alan Mertz, President of the American Clinical Laboratory Association (ACLA). The proposed fee was included in the health reform "framework" released by the Senate Finance Committee Chairman.

Mertz said, "The tax unfairly targets the clinical laboratory industry among providers, which includes about 40 thousand labs providing a myriad of critical health services to patients across the nation. When the $750 million in new fees are added to other cuts in the proposal, America's clinical labs could be facing cuts several times that of other providers."

"New fees will place an unnecessary access hurdle for laboratory services," added Mertz. "Clinical laboratory services are integral to realizing a key goal of health care reform -- building a new framework to enhance prevention and wellness." Laboratory tests provide critical information on which sound medical decisions can be made. It is estimated that 70% of all medical decisions are based on laboratory testing.

ACLA supports the goals of health reform and understands that everyone has to give to help achieve those goals. The laboratory community has demonstrated that support and willingness to do its fair share by agreeing to a reduction in future annual updates. However, ACLA strenuously objects to being singled out for additional cuts or taxes that are far beyond those taken by other providers.

Mertz concluded by saying that Medicare spending for laboratory tests has not kept pace with inflation. "Overall, Medicare payment amounts for clinical laboratory services have been reduced by about 40 percent in real, inflation-adjusted terms between 1984 and 2004," he said. "Congress has acted to completely eliminate the annual update for clinical labs in 10 of the last 12 years. Since 2000, laboratories have received the smallest cumulative update of any provider in Part B of Medicare, only 5.6% compared to 12% for physicians and 34% for hospitals."

ACLA represents local, regional and national clinical laboratories throughout the United States. For more information go to: http://www.clinical-labs.org/

    CONTACT: Alan Mertz
    202-637-9466


'/>"/>
SOURCE American Clinical Laboratory Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Consumers Union Opposes Over-the-Counter Cholesterol Drug
2. FTC Opposes Collective Bargaining for Providers in Puerto Rico
3. Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
4. Michigan Chamber of Commerce Opposes Blank Check Healthcare Ballot Proposal
5. AVMA Opposes Use of Double-Deck Trailers for Transporting Horses and Other Equines
6. Consumer Watchdog to U.S. Senate: Dont Leave Consumers Out of Health Reform Debate, Public Opposes Mandatory Purchases of Private Insurance & Supports Opening Medicare to Everyone
7. Association for Healthcare Philanthropy Opposes Limits on Charitable Tax Deductions
8. Physician Group Opposes FDA's Position on Adult Stem Cells
9. Local Medical Association Opposes Two State Propositions
10. Veterinary Group Opposes Bill to Clean Up Puppy Mill Industry
11. PIA Opposes Kennedy Proposal to Create Health Insurance "Navigators"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology: